← brief for 2026-09-14 · Slowing decline

Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

Trial No results yet Not peer reviewed

Key takeaways

A new trial is starting to test nalfurafine, a pill that calms the nerve signals behind itching, in people on peritoneal dialysis. Severe itching is common in dialysis and there are few good treatments. The plan is to enroll 93 people at several hospitals, and everyone gets the drug, with no comparison group. There are no results yet.

Who did this work

Run by Guangdong Provincial People's Hospital. Xueqing Yu (Guangdong Provincial People's Hospital)
Sites: Guangdong Provincial People's Hospital

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-09-14
https://clinicaltrials.gov/study/NCT07098351